Children's Hospital of Philadelphia Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2011
NCT01417026
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Erik Allen Jensen | Kristin Fiorino | Robert Schultz | Stephan Grupp MD PhD